EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 28-Oct-2026 23:16 ET (29-Oct-2026 03:16 GMT/UTC)

Trk and IGF1R-related signaling linked to delayed Ewing sarcoma growth

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – August 10, 2026 – A new research paper was published in Volume 17 of Oncotarget on August 7, 2026, titled “Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers.”

Journal: Oncotarget

UChicago Medicine Comprehensive Cancer Center partners with Lilly to expand clinical trial access

University of Chicago Medical Center
Business Announcement

The University of Chicago Medicine Comprehensive Cancer Center (UCCCC) and Eli Lilly and Company (Lilly) have partnered to help patients gain greater access to potential cancer treatments by participating in clinical trials.

Baylor College of Medicine signs multi-million-dollar agreement to advance xenoliver transplantation research

Baylor College of Medicine
Grant and Award Announcement

Baylor College of Medicine today announced that a new research agreement with United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, will provide up to $5 million a year for five years to establish the Baylor College of Medicine Center for Xenoliver Transplantation and Immunomodulation (XTI), dedicated to advancing scientific understanding of xenoliver transplantation.

Where women live may influence ovarian cancer survival, especially among Black women

University of Pittsburgh
Peer-Reviewed Publication

Study finds that neighborhood-level social disadvantage is linked to worse ovarian cancer survival, with a significantly greater impact among Black women.

Journal: JAMA Network Open
Funder: Congressionally Directed Medical Research Program, Janet Burroughs Ovarian Cancer Foundation

First- and second-year outcomes after Nirsevimab immunization

JAMA Network
Peer-Reviewed Publication

About the Study: This study found that nirsevimab was associated with a substantial reduction in RSV-LRTI–related hospitalizations during the first year across both the 2023-2024 and 2024-2025 seasons. It was not associated with reduced hospitalizations due to non-RSV infections or asthma, nor during the second year of follow-up.

Journal: JAMA Pediatrics

Physical fitness and all-cause mortality in older adults

JAMA Network
Peer-Reviewed Publication

About the Study: In this cohort study of older adults, objectively measured physical fitness—particularly balance and agility, lower-body strength, and cardiorespiratory fitness—was associated with lower all-cause mortality in a graded manner. These findings suggest that integrating objective fitness assessments into routine practice may refine risk stratification and guide function-oriented interventions in older adults.

Journal: JAMA Network Open

Dismantling independent science—the supreme court and public health regulation

JAMA Network
Peer-Reviewed Publication

About the Study: This Viewpoint summarizes the ways in which federal health agencies and state-level safeguards work in parallel to ensure public health and highlights how 3 recent Supreme Court rulings have reduced the independence of federal agencies, expanded political control over them, and curtailed state-level protections meant to challenge and supplement federal standards.

Journal: JAMA

Immune cells in bone marrow cancer: limited defense readiness

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Peer-Reviewed Publication

A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow in cases of multiple myeloma and acute myeloid leukemia: A specific group of tumor-reactive T cells can recognize and, in principle, fight cancer cells, but is often not sufficiently activated. Nevertheless, the number of these cells influences the prognosis. A specific gene signature identifies the tumor-reactive T cells and could predict the success of immunotherapies.

Journal: Cancer Cell

Molecular structures provide roadmap for targeted Parkinson’s disease therapeutics

Weill Cornell Medicine
Peer-Reviewed Publication

Researchers at Weill Cornell Medicine have uncovered how a key Parkinson's protein called LRRK2 shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.

Journal: Cell